Clinical Trial Update: TAK-329 Glucose Clamp Study [Phase 1]

View source ↗

Summary

Phase 1 glucose clamp study of TAK-329 in Type 1 Diabetes Mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• TAK-329

Snippet

Sponsor: Takeda | Conditions: Type 1 Diabetes Mellitus | Phase 1 | Status: COMPLETED